Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations ALHC Q1 2026 Earnings Strong Earnings Beat Signals Operational Progress DGICB Q1 2026 Earnings Earnings Miss Estimates as EPS Falls Short of Expectations Agree Realty Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Operational Performance ECC Q1 2026 Earnings Earnings Miss Estimates Amid Stable Portfolio Performance DB Q1 2026 Earnings Modest EPS Beat Amid Challenging Market Conditions